Citing Wardha case, guardian minister hints at changes in variant | Nagpur News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Minimally invasive cancer surgery centre opened at Gem Hospital
Updated:
Updated:
Share Article
AAA
District Collector K. Rajamani inaugurated Dr. Palanivelu’s Minimally Invasive Cancer Surgery Centre at Gem Hospital here on Wednesday.
The centre has announced conducting free cancer screening camps across the State throughout this year.
Hospital’s chairman C. Palanivelu said that incidence of cancer increased due to lifestyle and dietary habits and the hospital has been creating awareness on cancer among the public for early detection and treatment.
Pawanindra Lal, executive director of National Board of Examinations, launched a 24x7 cancer helpline, 98422-10174, and an email, cancerinfo@geminstitute.in.
Oxford/AstraZeneca vaccine set to clearance by year-end: Report
The Oxford University vaccine against coronavirus (COVID-19) being produced by AstraZeneca is likely to get regulatory approval from the U.K.’s independent regulator by the end of this year for a roll-out to begin in early 2021, according to a U.K. media report.
The Medicines and Healthcare Regulatory Agency (MHRA), which had been formally tasked by the U.K. government last month with the process of clearance after the jab emerged safe and effective against the novel coronavirus in human trials, is expected to authorise the vaccine by December 28 or 29 after the final data is provided on Monday,
Updated:
December 19, 2020 12:15 IST
Patients treated with indomethacin had a reduction in the number of days to become fever-free, and reduction in cough and muscle pain by half compared to the paracetamol set.
Share Article
AAA
Patients treated with indomethacin had a reduction in the number of days to become fever-free, and reduction in cough and muscle pain by half compared to the paracetamol set.
A pre-print published recently in
Medrxiv has advanced the case to use indomethacin, a drug conventionally used in the treatment of rheumatoid arthritis, for faster symptomatic relief and preventing progression of pneumonia in COVID-19 patients.
A total of 104 patients who had tested COVID-19 positive received the drug, along with standard care in two centres Narayana Medical College, Nellore, Andhra Pradesh, and Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra. The study was conceived by Rajan Ravichandran, senior nephrologist, MIOT Hospital, here, and execut